BELITE BIO, INC - Ordinary Shares, par value US$0.0001 per share (BLTE)
CUSIP: 07782B104
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Ordinary Shares, par value US$0.0001 per share
- Shares outstanding
- 37,379,062
- Total 13F shares
- 186,568
- Share change
- +128,456
- Total reported value
- $8,522,342
- Price per share
- $45.68
- Number of holders
- 11
- Value change
- +$5,980,161
- Number of buys
- 4
- Number of sells
- 8
Quarterly Holders Quick Answers
What is CUSIP 07782B104?
CUSIP 07782B104 identifies BLTE - BELITE BIO, INC - Ordinary Shares, par value US$0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 07782B104:
Top shareholders of BLTE - BELITE BIO, INC - Ordinary Shares, par value US$0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| STATE STREET CORP |
13F
|
Company |
0.04%
|
16,670
|
$639,628 | — | 31 Mar 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.03%
|
10,584
|
$406,108 | — | 31 Mar 2024 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.02%
|
8,700
|
$333,819 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.02%
|
6,700
|
$257,079 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.02%
|
6,090
|
$233,673 | — | 31 Mar 2024 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.01%
|
4,788
|
$183,716 | — | 31 Mar 2024 | |
| VIRTUS ADVISERS, LLC |
13F
|
Company |
0.01%
|
1,959
|
$75,167 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
1,724
|
$66,150 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
658
|
$25,247 | — | 31 Mar 2024 | |
| GAMMA Investing LLC |
13F
|
Company |
0%
|
234
|
$8,979 | — | 31 Mar 2024 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
5
|
$192 | — | 31 Mar 2024 |
Institutional Holders of BELITE BIO, INC - Ordinary Shares, par value US$0.0001 per share (BLTE) as of Q2 2024
As of 30 Jun 2024,
BELITE BIO, INC - Ordinary Shares, par value US$0.0001 per share (BLTE) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
186,568 shares.
The largest 10 holders included
ARMISTICE CAPITAL, LLC, STATE STREET CORP, Point72 Asset Management, L.P., GEODE CAPITAL MANAGEMENT, LLC, HRT FINANCIAL LP, Virtus ETF Advisers LLC, MORGAN STANLEY, GAMMA Investing LLC, BANK OF AMERICA CORP /DE/, and JPMORGAN CHASE & CO.
This page lists
11
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
11
Q2 2024 holders
11
Holder diff
0
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.